Last reviewed · How we verify

NCT05517967: Born2Burn

An Examination of Brown Adipose Tissue and Energy Expenditure in Infants

Recruiting now Last updated 31 May 2025
What this trial tests

trial in Cold Induced Thermogenesis in 60 participants. Currently enrolling.

Timeline
17 August 2022
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorPennington Biomedical Research Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date17 August 2022
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across United States

Conditions studied

Sponsor

Pennington Biomedical Research Center — full company profile →

Who can join

Under 5 Weeks, any sex, with Cold Induced Thermogenesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Excess fetal adipose tissue growth during intrauterine development increases future obesity risk. Development of brown adipose tissue, a highly thermogenic organ in utero, may affect postnatal energy expenditure, thus influencing obesity risk. This pilot research study is designed to understand the developmental origins of energy balance by examining maternal and neonatal factors that influence neonatal brown adipose tissue and to quantify its physiological relevance to energy expenditure in human neonates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pennington Biomedical Research Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing